On 9 October 2012, in a Phase II randomized and controlled multicenter clinical trial, the first subject was successfully treated with Skingenix’s investigational product in USA. This clinical study is currently ongoing, in which a total of 35 patients with Diabetic Foot Ulcers will be treated with the investigational product. The study is currently recruiting eligible patients with Diabetic Foot Ulcers and is expected to be completed in 2013. For further details, please visit clinicaltrials.gov website.